| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/04/2007 | CN1940063A Pseudo-rabies gE/gI-gene loss poison strain, killed vaccine containing it and use |
| 04/04/2007 | CN1940061A Young beet armyworms fat body cell system for producing baculiform virus with high yields |
| 04/03/2007 | USRE39544 Viral obesity methods and compositions |
| 04/03/2007 | US7198951 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 04/03/2007 | US7198950 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents |
| 04/03/2007 | US7198935 Infectious pestivirus pseudo-particles containing functional Erns, E1, E2 envelope proteins |
| 04/03/2007 | US7198934 Genetic engineering; gene insertion; culture product |
| 04/03/2007 | US7198923 Method for the preparation of purified HCV RNA by exosome separation |
| 04/03/2007 | US7198792 Alphaviral vector system comprising papilloma viral orgin of replication and antitumor agent for prevention and treatment urogenital cancer; gene therapy |
| 04/03/2007 | CA2238295C Complementary adenoviral vector systems and cell lines |
| 03/29/2007 | WO2007035856A2 Systems for detection and production of respiratory, herpes and enteric viruses |
| 03/29/2007 | WO2007035082A1 Immortalized fetal liver cell lines |
| 03/29/2007 | WO2007034742A1 Method of treating virus-infected biological substance and cell, tissue and organ having been subjected to treatment against infecting virus |
| 03/29/2007 | WO2006124044A3 Protein scaffolds and viral particles for detecting analytes |
| 03/29/2007 | WO2006066224A3 Virulence targeted antibiotics |
| 03/29/2007 | US20070072282 Bovine adeno-associated viral (baav) vector and uses thereof |
| 03/29/2007 | US20070072207 Production of vaccines |
| 03/29/2007 | US20070072191 Infectious pestivirus pseudo-particles containing functional erns, e1, e2 envelope proteins |
| 03/29/2007 | US20070071775 Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination |
| 03/29/2007 | US20070071770 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071769 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071726 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum; ntigenic determinant comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 03/29/2007 | US20070071725 Nitric oxide synthase gene transfer |
| 03/29/2007 | CA2623290A1 Systems for detection and production of respiratory, herpes and enteric viruses |
| 03/28/2007 | EP1767642A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 03/28/2007 | EP1766059A2 Influenza hemagglutinin and neuraminidase variants |
| 03/28/2007 | EP1766008A1 Phage screening assay |
| 03/28/2007 | EP1765990A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 03/28/2007 | EP1765392A2 Apoptosis-inducing polypeptides |
| 03/28/2007 | EP1010759B1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus |
| 03/28/2007 | CN1938420A Use of proteins and peptides coded by the genome of a novel strain of SARS-associated coronavirus |
| 03/28/2007 | CN1935258A West nile vaccine |
| 03/27/2007 | US7195905 Enveloped virus vaccine and method for production |
| 03/27/2007 | US7195866 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 03/22/2007 | WO2006125821A3 Scalable fermentation process |
| 03/22/2007 | WO2006028591A3 Novel recombinant t4 phage particles and uses thereof |
| 03/22/2007 | US20070065939 Systems for detection and production of respiratory, herpes and enteric viruses |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065852 HIV recombinant vaccine |
| 03/22/2007 | US20070065457 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 03/21/2007 | CN1934257A Process for producing virus vector |
| 03/21/2007 | CN1934248A HBV variants detection and application |
| 03/21/2007 | CN1934243A Immortalized avian cell lines for virus production |
| 03/21/2007 | CN1934131A Optimized expression of hpv 52 l1 in yeast |
| 03/21/2007 | CN1933852A Improved inactivated FCV vaccines |
| 03/21/2007 | CN1306033C Production of vaccines |
| 03/20/2007 | US7192759 infecting human embryonic retinoblast with an influenza virus, then culturing and allowing for expression of said influenza virus and influenza viral protein, and harvesting influenza virus and/or influenza viral protein uses as vaccines |
| 03/20/2007 | US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 03/20/2007 | US7192594 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 03/20/2007 | CA2256696C Modified small rna viruses |
| 03/15/2007 | WO2006136704A3 Cdna construct of salmonidae alphavirus |
| 03/15/2007 | US20070059290 Transcriptional regulation of target genes |
| 03/14/2007 | EP1343897B1 Purified active hcv ns2/3 protease |
| 03/14/2007 | EP1226169B1 Molecular structure of rhd negative locus |
| 03/14/2007 | EP1196197B1 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| 03/14/2007 | CN1930284A Infectious bursal disease virus antigenic isolates and vaccines |
| 03/14/2007 | CN1926991A Producing method of gene recombination nucleopolyhedrosis virus pesticide and application thereof |
| 03/14/2007 | CN1304579C Recombinant vaccine using flavivirus as vector |
| 03/14/2007 | CN1304559C Oncolytic microorganism expressing heat shock protein and its application |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189536 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus |
| 03/13/2007 | US7189401 Modified viral geomes for use in vectors or vaccines. Replication of DNA or DNA polymerase |
| 03/13/2007 | CA2259460C Recombinant canine adenovirus (cav) containing exogenous dna |
| 03/13/2007 | CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 03/13/2007 | CA2101463C Recombinant adenovirus vaccines |
| 03/08/2007 | WO2007026146A1 Treatment using herpes simplex virus |
| 03/08/2007 | WO2007025431A1 Recombinant newcastle disease lasota attenuated vaccine strain expressing vp2 gene of infectious bursal disease virus |
| 03/08/2007 | WO2007025365A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 03/08/2007 | US20070054401 Composition for intracellular transport of biological particles or macromolecules |
| 03/08/2007 | US20070054396 Cell line and methods for determining viral titer |
| 03/08/2007 | US20070053878 Sars |
| 03/08/2007 | CA2621127A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 03/07/2007 | EP1760154A2 sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell |
| 03/07/2007 | EP1760151A1 An improved method for the production and purification of adenoviral vectors |
| 03/07/2007 | EP1758925A2 Recombinant icosahedral virus like particle production in pseudomonads |
| 03/07/2007 | EP1758640A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 03/07/2007 | EP1131414B1 Stable, attenuated rabies virus mutants and live vaccines thereof |
| 03/07/2007 | EP1060241B1 Preparation of cells for production of biologicals |
| 03/06/2007 | US7186543 Adding an effective amount of an endogengous isoalloxazine photosensitizer to the one or more infectious particles and exposing the particles to light of a sufficient wavelength to prevent replication of the infectious particles but not substantially destroy the antigenic determinants of the particles |
| 03/06/2007 | US7186542 Generation and recovering of preferential viral particles; obtain cells, infect with virus, extract virus from cells using detergent, recover virus |
| 03/06/2007 | US7186504 Cells for detection of enteroviruses |
| 03/01/2007 | WO2007023628A1 Secretory antigen 1 protein of babesia gibsoni, dna encoding the same and use thereof |
| 03/01/2007 | WO2006110589A8 Gammaretrovirus associated with cancer |
| 03/01/2007 | US20070050859 Selecting a codon of a parent polynucleotide that encodes a polypeptide for replacement with a synonymous codon, replacing the codon with synonymous codon (corresponds to an iso-tRNA ) to form a synthetic polynucleotide and introducing into a mammal cell |
| 03/01/2007 | US20070048862 Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines |
| 03/01/2007 | US20070048330 Optimized multi-epitope constructs and uses thereof |
| 02/28/2007 | EP1757703A2 Self-inactivating retroviral vector |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757312A1 Freeze-dried composition of inactivated virus envelope with membrane fusion activity |
| 02/28/2007 | EP1756287A2 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 02/28/2007 | EP1755539A2 Flavivirus vaccines |
| 02/28/2007 | EP1406642B1 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 02/28/2007 | EP1224310B1 Recombinant adenoviruses preparation and adenovirus banks |
| 02/28/2007 | EP1025209B1 An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
| 02/28/2007 | CN1922309A A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 02/28/2007 | CN1922308A Virus purification methods |
| 02/28/2007 | CN1922197A Targeted delivery of rna interference molecules |
| 02/27/2007 | USRE39494 Vaccine mixture of attenuated or killed immunogen of Mycoplasma hypopneumoniae bacteria, and Bordetella or Pasteurella vaccine against swine disease; diagnosis |
| 02/27/2007 | US7183401 Tumor suppressor protein (designated NOEY2) expressed in normal ovarian and breast surface epithelial cells but absent or down-regulated in ovarian and breast cancer cells; vectors, host cells, detection kits |
| 02/27/2007 | US7183107 Enhanced replication of HCV RNA |